StandardStandard

Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis. / Hughes, D.; Hughes, D.A.; Al-Zubiedi, S. et al.
2009. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..

Allbwn ymchwil: Cyfraniad at gynhadleddPapur

HarvardHarvard

Hughes, D, Hughes, DA, Al-Zubiedi, S, Hanson, A, Jorgensen, A & Pirmohamed, M 2009, 'Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.', Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009., 3/01/02.

APA

Hughes, D., Hughes, D. A., Al-Zubiedi, S., Hanson, A., Jorgensen, A., & Pirmohamed, M. (2009). Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..

CBE

Hughes D, Hughes DA, Al-Zubiedi S, Hanson A, Jorgensen A, Pirmohamed M. 2009. Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..

MLA

Hughes, D. et al. Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.. 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009., 03 Ion 0002, Papur, 2009.

VancouverVancouver

Hughes D, Hughes DA, Al-Zubiedi S, Hanson A, Jorgensen A, Pirmohamed M. Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.. 2009. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..

Author

Hughes, D. ; Hughes, D.A. ; Al-Zubiedi, S. et al. / Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..

RIS

TY - CONF

T1 - Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.

AU - Hughes, D.

AU - Hughes, D.A.

AU - Al-Zubiedi, S.

AU - Hanson, A.

AU - Jorgensen, A.

AU - Pirmohamed, M.

PY - 2009/1/1

Y1 - 2009/1/1

M3 - Paper

T2 - 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009.

Y2 - 3 January 0002

ER -